Dr. Dalton Duane Baldwin, MD

Dr. Baldwin practices at Loma Linda University Medical Cente - Center for Restorative Neurology - HOPD in Loma Linda, California.

Dr. Baldwin's NPI, 1205927837, was assigned on September 27, 2006. Dr. Baldwin graduated from Loma Linda University School Of Medicine in 1991. Dr. Baldwin holds California license G75384.

Dr. Baldwin's primary practice is Loma Linda University Medical Cente - Center for Restorative Neurology - HOPD, at 11370 Anderson St, Loma Linda, CA 92354.

Dr. Baldwin's primary practice is Loma Linda University Medical Cente - Center for Restorative Neurology - HOPD in Loma Linda, California. Dr. Baldwin is also affiliated with Loma Linda University Medical Center. The medical group on file is Loma Linda University Faculty Medical Group (LLUFMG). Dmand AI also links Dr. Baldwin to 1 more hospital, 1 group practice or clinic and 1 hospital outpatient department, each named with a free account. Dr. Baldwin's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Baldwin practices, 5 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Baldwin's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Baldwin is board certified in urology by the American Board of Urology. Dmand AI has Dr. Baldwin's licenses on file in 2 states: California and Tennessee.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), kidney removal surgery, kidney stone disease, prostate cancer, prostate inflammation or infection and prostate surgery among the conditions Dr. Baldwin treats.

CMS data shows 541 Medicare services from Dr. Baldwin across 16 procedure codes in 2024, for 265 Medicare patients. Medicare paid $75,079 for them.

CMS counts 265 Medicare patients who saw Dr. Baldwin in 2024. The largest group is 65 to 74, with 120 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 35% are also on Medicaid. Their average risk score is 2.25, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Baldwin's median patient age at 70, with 41% women.

In 2024, Dr. Baldwin wrote 606 Medicare Part D claims for 167 patients. 96% of them were for generic drugs. CMS names the drug for 508 of them, across 11 drugs with 11 or more claims each, at $17,342 in total drug cost. In 2023, CMS named 445 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Baldwin for performance year 2024, reported as part of a group. Dr. Baldwin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Baldwin as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 45 papers to Dr. Baldwin, published from 2007 to 2020. 2017 was the busiest year, with 4. The most frequent topics are Laparoscopy, Nephrectomy and Ureteroscopy. Dr. Baldwin has published most often in J Endourol. Dr. Baldwin's most frequent co-authors are Muhannad Mahmoud Alsyouf, MD, Roger Li, MD and Gaudencio Olgin, MD.

CMS Open Payments shows 146 general payments to Dr. Baldwin from 27 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 46% of the total. Olympus Corporation paid the most, $24,386. It also lists 2 research payments totaling $1,435 in 2016.

Dmand AI lists 1 award for Dr. Baldwin, most recently CMS Stage 1 EHR in 2013.

Dr. Baldwin graduated from Loma Linda University School Of Medicine in 1991.

Dr. Baldwin is in network with 9 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.